Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$6.75 - $11.15 $10,125 - $16,725
-1,500 Closed
0 $0
Q1 2018

May 16, 2018

BUY
$20.86 - $26.6 $29,746 - $37,931
1,426 Added 1927.03%
1,500 $35,000
Q4 2017

May 18, 2018

SELL
$20.9 - $49.36 $15,737 - $37,168
-753 Reduced 91.05%
74 $37,000
Q4 2017

Mar 07, 2018

BUY
$20.9 - $49.36 $17,284 - $40,820
827
827 $36,000

Others Institutions Holding DBVT

About DBV Technologies S.A.


  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $732M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.